{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-056089","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.734124+00:00","generated_at":"2026-06-02T07:03:21.023097+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeStance Q1 revenue +19% to $300.4M; raises FY2024 EBITDA guidance; COO to depart June 30","bullets":["Q1 revenue $300.4M (+19% YoY); net loss narrowed to $21.1M from $34.2M.","Adjusted EBITDA $27.7M (9.2% of revenue), up from $10.1M; FY2024 Adjusted EBITDA guidance raised to $88–$98M.","Clinician base grew 15% to 6,866; visit volumes up 15% to 1.9M; Center Margin $94.7M (31.5% of revenue).","President & COO Danish Qureshi notified departure effective June 30, 2024.","Q2 2024 guidance: revenue $297–$315M, Adjusted EBITDA $20–$26M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-056089","json":"https://secwatch.observer/filing/0000950170-24-056089.json","markdown":"https://secwatch.observer/filing/0000950170-24-056089.md","text":"https://secwatch.observer/filing/0000950170-24-056089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/0000950170-24-056089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/lfst-20240506.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T07:03:21.023097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"039c77c912033848f1b7fde7126020c67c72b0cd","claim":"LifeStance Health Group, Inc. reported the first quarter ended March 31, 2024 results: revenue $300.4 million, net income ($21.1 million). Guidance raised.","evidence_excerpt":"LifeStance Reports First Quarter 2024 Results SCOTTSDALE, Ariz. – May 9, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2024. (All results compared to prior-year comparative period, unless otherwise noted) Q1 2024 Highlights and FY 2024 Outlook • Revenue of $300.4 million increased 19% compared to revenue of $252.6 million • Clinician base increased 15% to 6,866 clinicians, a sequential net increase of 221 in the first quarter • First quarter visit volumes increased 15% to 1.9 million • Net loss of $21.1 million, primarily driven by stock-based compensation, compared to net loss of $34.2 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/0000950170-24-056089-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Revenue","value":"$300.4 million"},{"label":"Net income","value":"($21.1 million)"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"9563958b51","claim":"Danish Qureshi departed as President and Chief Operating Officer at LifeStance Health Group, Inc..","evidence_excerpt":"On May 6, 2024, Danish Qureshi, the President and Chief Operating Officer of LifeStance Health Group, notified the Company of his decision to depart the Company, effective June 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/0000950170-24-056089-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"notified his decision to depart"},{"label":"Role","value":"President and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}